Position
Chief Medical Officer
Company
Inimmune Corporation
MissoulaBiotechnologyHealth CareTherapeuticsDescription
Inimmune Corporation announced the appointments of Ferdinand Massari, M.D., as Chief Medical Officer and Ryan McMillian as Head of Financial Strategy. These appointments strengthen the leadership team as Inimmune advances its lead allergic rhinitis program.
Quick answer
Inimmune Corporation Appoints Ferdinand Massari as Chief Medical Officer (March 5, 2026). Inimmune Corporation is based in Missoula, Montana, United States.
- Who is the new Chief Medical Officer at Inimmune Corporation?
- Inimmune Corporation named Ferdinand Massari Chief Medical Officer, announced March 5, 2026.
- What did Inimmune Corporation announce on March 5, 2026?
- Inimmune Corporation announced the appointments of Ferdinand Massari, M.D., as Chief Medical Officer and Ryan McMillian as Head of Financial Strategy. These appointments strengthen the leadership team as Inimmune advances its lead allergic rhinitis program.
- What does Inimmune Corporation do?
- Inimmune is a clinical-stage biotechnology company focused on the discovery and development of next-generation immunotherapies for the treatment of infectious diseases, allergy, and cancer.
- Where is Inimmune Corporation based?
- Inimmune Corporation is based in Missoula, Montana, United States.
- Which similar companies made leadership changes around the same time?
- XyloCor Therapeutics (March 5, 2026), Lakefront Biotherapeutics NV (March 6, 2026), Royalty Pharma plc (March 3, 2026) and Seres Therapeutics (March 2, 2026) also announced leadership changes within 45 days of Inimmune Corporation.
Source: Fundz verified event record.
Other recent leadership changes in Therapeutics and Biotechnology
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- XyloCor Appoints John Tucker as Chief Executive Officer (March 5, 2026)
- Galapagos NV Appoints Tania Philipp as Chief Human Resources Officer (March 6, 2026)
- Royalty Pharma Appoints Kenneth Sun as Senior Vice President and Head of Asia (March 3, 2026)
- Seres Therapeutics Appoints New Executive Leadership (March 2, 2026)
- Argo Biopharma Appoints Gena Wang as Chief Financial Officer and Chief Strategy Officer (March 2, 2026)
- BiomX Appoints Michael Oster as Chief Executive Officer and David Rokach as Chief Financial Officer (March 9, 2026)
Who to call at Inimmune Corporation, and when
A new leader at Inimmune Corporation brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day Inimmune Corporation raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Inimmune Corporation, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Inimmune Corporation. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Inimmune Corporation changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Inimmune Corporation changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.